MedVenture Partners, Inc. — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Avisi Technologiesavisitech.comin𝕏Jul 2022✓ verified
Avisi Technologies develops nanotechnology-enabled implantable devices to lower intraocular pressure in patients with open-angle glaucoma.
Deep TechHealthtechMedical DevicesPhiladelphia, US
Rui Jing Jiang(Ms. Jiang is the Chief Executive Officer of the Issuer.)inPaul Norris(Director)inBrandon Kao(Director)inGary Pruden(Director)in
BoardCatherine Mohr(Director)in
Co-investorsGolden SeedsGood Growth CapitalLife Sciences Greenhouse Investments
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.